Nkarta Inc (NKTX) support and resistance · $188.9M cap
Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
This page maps Nkarta Inc (NKTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
NKTX currently screens at market cap $188.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NKTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NKTX quote page for the session range and the stock page for the full model.
Not investment advice.